The Food and Drug Administration (FDA) told the maker of Purell to discontinue marketing campaigns that includes claims for avoiding flu and ebola, according to an article on The New York Times website.
The campaigns also claim the product can prevent spread of MRSA and norovirus.
The FDA told Gojo Industries that its claims that Purell could reduce the potential for infection or prevent illnesses violated the Federal Food, Drug and Cosmetic Act.
The agency said it was reclassifying Purell as an unapproved drug, rather than an over-the-counter product.
Grounding Healthcare Spaces in Hospitality Principles
UC Davis Health Selects Rudolph and Sletten for Central Utility Plant Expansion
Cape Cod Healthcare Opens Upper 2 Floors of Edwin Barbey Patient Care Pavilion
Building Sustainable Healthcare for an Aging Population
Froedtert ThedaCare Announces Opening of ThedaCare Medical Center-Oshkosh